Intra-Cellular Therapies Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Market Capitalization	112,150	103,523	98,922	86,270	74,000	-
Market Cap Growth	-12.15%	4.65%	14.67%	16.58%	-	-
Enterprise Value	177,637	154,432	149,525	162,351	69,787	-
Last Close Price	7500.00	6923.08	6615.38	5769.23	4631.08	-
PE Ratio	8.62	7.37	5.56	4.40	2.88	-
PS Ratio	0.35	0.53	0.54	0.33	0.30	-
PB Ratio	0.72	0.68	0.71	0.71	0.97	-
P/TBV Ratio	0.72	0.68	0.71	0.71	0.97	-
P/OCF Ratio	-	-	3.28	-	4.57	-
EV/Sales Ratio	0.56	0.79	0.81	0.62	0.28	-
EV/EBIT Ratio	10.50	8.48	6.26	6.94	2.34	-
Debt / Equity Ratio	0.50	0.44	0.38	0.84	-	-
Asset Turnover	-	0.82	0.78	-	2.36	-
Inventory Turnover	-	1.96	1.77	-	8.98	-
Quick Ratio	1.43	1.44	1.27	1.06	2.18	2.45
Current Ratio	2.05	2.35	2.52	1.87	2.69	3.53
Return on Equity (ROE)	-	9.65%	13.70%	-	35.94%	-
Return on Assets (ROA)	-	4.77%	6.30%	-	17.84%	-
Return on Capital (ROIC)	-	5.56%	7.22%	-	26.09%	-
Return on Capital Employed (ROCE)	10.60%	11.60%	16.50%	17.70%	38.90%	25.50%
Earnings Yield	11.60%	13.56%	17.99%	22.73%	34.76%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.